26 related articles for article (PubMed ID: 7604207)
1. The State-of-the-Art Mechanisms and Antitumor Effects of Somatostatin in Colorectal Cancer: A Review.
Kasprzak A; Geltz A
Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540191
[TBL] [Abstract][Full Text] [Related]
2. Regulation of colonic apical potassium (BK) channels by cAMP and somatostatin.
Perry MD; Sandle GI
Am J Physiol Gastrointest Liver Physiol; 2009 Jul; 297(1):G159-67. PubMed ID: 19407217
[TBL] [Abstract][Full Text] [Related]
3. Effect of a novel somatostatin analogue combined with cytotoxic drugs on human tumour xenografts and metastasis of B16 melanoma.
Szende B; Horváth A; Bökönyi G; Kéri G
Br J Cancer; 2003 Jan; 88(1):132-6. PubMed ID: 12556972
[TBL] [Abstract][Full Text] [Related]
4. A tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activity.
Kéri G; Erchegyi J; Horváth A; Mezõ I; Idei M; Vántus T; Balogh A; Vadász Z; Bökönyi G; Seprõdi J; Teplán I; Csuka O; Tejeda M; Gaál D; Szegedi Z; Szende B; Roze C; Kalthoff H; Ullrich A
Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12513-8. PubMed ID: 8901613
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory and stimulatory effects of somatostatin on two human pancreatic cancer cell lines: a primary role for tyrosine phosphatase SHP-1.
Douziech N; Calvo E; Coulombe Z; Muradia G; Bastien J; Aubin RA; Lajas A; Morisset J
Endocrinology; 1999 Feb; 140(2):765-77. PubMed ID: 9927304
[TBL] [Abstract][Full Text] [Related]
6. The activation of the phosphotyrosine phosphatase eta (r-PTP eta) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation.
Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Pattarozzi A; Bajetto A; Trapasso F; Fusco A; Schettini G
Mol Endocrinol; 2001 Oct; 15(10):1838-52. PubMed ID: 11579215
[TBL] [Abstract][Full Text] [Related]
7. Exogenous phosphotyrosine modulates epidermal growth factor receptor tyrosine phosphorylation.
Mishra S; Hamburger AW
Carcinogenesis; 1993 Feb; 14(2):269-73. PubMed ID: 7679612
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2.
Buscail L; Delesque N; Estève JP; Saint-Laurent N; Prats H; Clerc P; Robberecht P; Bell GI; Liebow C; Schally AV
Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2315-9. PubMed ID: 7907795
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of a membrane tyrosine phosphatase activity by somatostatin analogues in rat pancreatic acinar cells.
Colas B; Cambillau C; Buscail L; Zeggari M; Esteve JP; Lautre V; Thomas F; Vaysse N; Susini C
Eur J Biochem; 1992 Aug; 207(3):1017-24. PubMed ID: 1499547
[TBL] [Abstract][Full Text] [Related]
10. The tumor-selective somatostatin analog, TT2-32 induces a biphasic activation of phosphotyrosine phosphatase activity in human colon tumor cell line, SW620.
Vántus T; Csermely P; Teplán I; Kéri G
Tumour Biol; 1995; 16(4):261-7. PubMed ID: 7604207
[TBL] [Abstract][Full Text] [Related]
11. Positive and negative regulation of T-cell activation through kinases and phosphatases.
Mustelin T; Taskén K
Biochem J; 2003 Apr; 371(Pt 1):15-27. PubMed ID: 12485116
[TBL] [Abstract][Full Text] [Related]
12. Recent patents related to phosphorylation signaling pathway on cancer.
Acosta KB; Tibolla MM; Tiscornia MM; Lorenzati MA; Zapata PD
Recent Pat DNA Gene Seq; 2011 Dec; 5(3):175-84. PubMed ID: 21827380
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
